Mehmet Asik
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Mehmet Asik has a total of 94 co-authors. Here are the top co-authors by number of shared publications:
- Erdem Akbal
Department of Internal Medicine, Ankara Education and Research Hospital, Ministry of Health, Ankara, Turkey
7 shared publications Hacer Sen
General Medicine, Faculty of Medicine, Çanakkale Onsekiz Mart University, Çanakkale, Turkey
7 shared publications- Kubilay Ukinc
Endocrinology and Metabolism Department, LİV Hospital Vadistanbul, İstanbul, Turkey
7 shared publications Emine Binnetoglu
6 shared publicationsFahri Gunes
6 shared publicationsMustafa Eroglu
Departments of Endocrinology and Metabolism, Faculty of Medicine, Çanakkale Onsekiz Mart University, Çanakkale, Turkey
5 shared publications
Latest Publications
- 31 July 2022
- Published by Family Practice and Palliative Care in Family Practice and Palliative Care
- Vol. 7 (3) , 77-83
SIRS tanılı hastalarda enflamasyon ve kemik döngüsü arasındaki ilişkinin sklerostin ve Dickkopf-1 (DKK-1) düzeyleri ile değerlendirilmesi
Introduction: In intensive care units (ICU), patients remain bedridden for a long time. In addition, severe infections are frequently seen in ICUs. Both prolonged immobilization and serious infections are associated with bone tissue loss. The Wnt pathway has recently been focused on evaluating bone tissue loss. The Wnt pathway participates in both infections and the formation of bone tissue. Wnt pathway inhibitors sclerostin and Dickkopf-1 (DKK-1) inhibit bone formation and increase osteoclastic activity. In this study, we aimed to examine bone turnover by the Wnt inhibitors sclerostin and DKK-1 and their possible associations with inflammation in SIRS patients.Methods: We included 30 patients diagnosed with systemic inflammatory response syndrome (SIRS) in the study group and 16 in the control group. Serum sclerostin, DKK-1, white blood cell (WBC), and C-Reactive Protein (CRP) levels on the day of SIRS diagnosis (basal), the 7th, 14th, and 21stdays were evaluated in the study group, and the results were compared with the control group.Results: When the control group was compared with the basal SIRS, there was a significant elevation in both sclerostin (p=0.003) and DKK-1 (p=0.001). Statistical analysis showed significant decreases in sclerostin levels between basal and the 7th, 14th, and 21st days (p=0.033, p=0.003, p=0.002, respectively). Similarly, significant decreases in DKK-1 levels between basal and the 7th and 21st days (p=0.015, p=0.001, respectively) and an insignificant decrease on the 14th day (p=0.191) was observed. Sclerostin was positively and significantly correlated with WBC and CRP in basal and 7th-day measurements and WBC in 7th and 14th days. DKK-1 is positively and significantly correlated with WBC in basal and 7th-daymeasurements, while DKK-1 negatively correlates with CRP in basal-7th-day measurements.Conclusion: In this study, it was shown for the first time that the Wnt antagonists sclerostin and DKK-1 values are high in SIRS patients in ICU. Both biomarker levels decreased in parallel with the treatment. However, it could not be associated with disease severity and inflammatory marker levels. We believe that monitoring the change of Wnt antagonists will be useful in demonstrating bone turnover in patients with SIRS.Keywords: Dickkopf-1, Intensive care unit, Sclerostin, Systemic inflammatory response syndrome, Wnt signaling pathway, Bone turnover
- 31 July 2022
- Published by Family Practice and Palliative Care in Family Practice and Palliative Care
- Vol. 7 (3) , 77-83
SIRS tanılı hastalarda enflamasyon ve kemik döngüsü arasındaki ilişkinin sklerostin ve Dickkopf-1 (DKK-1) düzeyleri ile değerlendirilmesi
Introduction: In intensive care units (ICU), patients remain bedridden for a long time. In addition, severe infections are frequently seen in ICUs. Both prolonged immobilization and serious infections are associated with bone tissue loss. The Wnt pathway has recently been focused on evaluating bone tissue loss. The Wnt pathway participates in both infections and the formation of bone tissue. Wnt pathway inhibitors sclerostin and Dickkopf-1 (DKK-1) inhibit bone formation and increase osteoclastic activity. In this study, we aimed to examine bone turnover by the Wnt inhibitors sclerostin and DKK-1 and their possible associations with inflammation in SIRS patients.Methods: We included 30 patients diagnosed with systemic inflammatory response syndrome (SIRS) in the study group and 16 in the control group. Serum sclerostin, DKK-1, white blood cell (WBC), and C-Reactive Protein (CRP) levels on the day of SIRS diagnosis (basal), the 7th, 14th, and 21stdays were evaluated in the study group, and the results were compared with the control group.Results: When the control group was compared with the basal SIRS, there was a significant elevation in both sclerostin (p=0.003) and DKK-1 (p=0.001). Statistical analysis showed significant decreases in sclerostin levels between basal and the 7th, 14th, and 21st days (p=0.033, p=0.003, p=0.002, respectively). Similarly, significant decreases in DKK-1 levels between basal and the 7th and 21st days (p=0.015, p=0.001, respectively) and an insignificant decrease on the 14th day (p=0.191) was observed. Sclerostin was positively and significantly correlated with WBC and CRP in basal and 7th-day measurements and WBC in 7th and 14th days. DKK-1 is positively and significantly correlated with WBC in basal and 7th-daymeasurements, while DKK-1 negatively correlates with CRP in basal-7th-day measurements.Conclusion: In this study, it was shown for the first time that the Wnt antagonists sclerostin and DKK-1 values are high in SIRS patients in ICU. Both biomarker levels decreased in parallel with the treatment. However, it could not be associated with disease severity and inflammatory marker levels. We believe that monitoring the change of Wnt antagonists will be useful in demonstrating bone turnover in patients with SIRS.Keywords: Dickkopf-1, Intensive care unit, Sclerostin, Systemic inflammatory response syndrome, Wnt signaling pathway, Bone turnover
- 18 July 2022
- Published by Afyon Kocatepe University in Kocatepe Tıp Dergisi
- Vol. 23 (3) , 252-256
POLİKİSTİK OVER SENDROMLU HASTALARDA SERUM SKLEROSTİN VE DİCKKOPF-1 SEVİYELERİ
AMAÇ: Polikistik over sendromu (PKOS), premenopozal kadınlarda en sık görülen endokrin patolojidir ve çeşitli sistemleri etkileyen karmaşık bir sendromdur. PKOS'un kemik metabolizması üzerindeki etkileri hakkında çok sayıda çalışma yapılmıştır, ancak PKOS’da osteoporoz riski konusundaki veriler çelişkilidir. Wingless-type mouse mammary tumor virus integration site (Wnt) yolu, kemik metabolizmasının düzenlenmesinde önemli rol oynar. Bu yolun inhibitörleri olarak Sklerostin (Scl) ve Dickkopf-1 (DKK1) son zamanlarda osteoporozun terapötik tedavisiiçin hedefler haline gelmiştir. Bu çalışma, PKOS'lu kadınlarda Scl ve DKK1 düzeylerini belirlemeyi amaçlamıştır.GEREÇ VE YÖNTEM: Bu çalışmada PKOS tanısı konulmuş 36 kadın ve 35 sağlıklı gönüllü retrospektif olarak incelendi. Her iki grup, demografik, antropometrik, biyokimyasal parametrelerin yanı sıra Scl ve DKK1 seviyeleri açısından karşılaştırıldı.BULGULAR: Scl seviyesi, PKOS grubunda 42,68 ± 13,28 pg / mL ve kontrol grubunda 45,69 ± 11,79 pg / mL idi ve istatistiksel olarak benzerdi. DKK1 seviyesi, PKOS grubunda 1444,73 ± 611,30 pg / mL ve kontrol grubunda 1204,26 ± 660,88 pg / mL idi ve istatistiksel olarak benzerdi. PKOS grubunun vücut kitle indeksi (VKİ) ve bel/kalça oranı (BKO) değerleri, istatistiksel olarak anlamlı olmamasına rağmen, kontrol grubuna göre daha yüksekti.SONUÇ: Bu çalışma, PKOS'lu kadınlarla sağlıklı bireyler arasında, Scl ve DKK1 düzeyleri bakımından anlamlı bir fark olmadığını göstermiştir. Amenore PKOS olgularında kemik kaybına neden olsa da, hiperandrojenemi ve hiperöstrojeneminin kemik yoğunluğu üzerindeki olumlu etkileri dengeleyici bir unsur olarak kabul edilebilir.
- 18 July 2022
- Published by Afyon Kocatepe University in Kocatepe Tıp Dergisi
- Vol. 23 (3) , 252-256
POLİKİSTİK OVER SENDROMLU HASTALARDA SERUM SKLEROSTİN VE DİCKKOPF-1 SEVİYELERİ
AMAÇ: Polikistik over sendromu (PKOS), premenopozal kadınlarda en sık görülen endokrin patolojidir ve çeşitli sistemleri etkileyen karmaşık bir sendromdur. PKOS'un kemik metabolizması üzerindeki etkileri hakkında çok sayıda çalışma yapılmıştır, ancak PKOS’da osteoporoz riski konusundaki veriler çelişkilidir. Wingless-type mouse mammary tumor virus integration site (Wnt) yolu, kemik metabolizmasının düzenlenmesinde önemli rol oynar. Bu yolun inhibitörleri olarak Sklerostin (Scl) ve Dickkopf-1 (DKK1) son zamanlarda osteoporozun terapötik tedavisiiçin hedefler haline gelmiştir. Bu çalışma, PKOS'lu kadınlarda Scl ve DKK1 düzeylerini belirlemeyi amaçlamıştır.GEREÇ VE YÖNTEM: Bu çalışmada PKOS tanısı konulmuş 36 kadın ve 35 sağlıklı gönüllü retrospektif olarak incelendi. Her iki grup, demografik, antropometrik, biyokimyasal parametrelerin yanı sıra Scl ve DKK1 seviyeleri açısından karşılaştırıldı.BULGULAR: Scl seviyesi, PKOS grubunda 42,68 ± 13,28 pg / mL ve kontrol grubunda 45,69 ± 11,79 pg / mL idi ve istatistiksel olarak benzerdi. DKK1 seviyesi, PKOS grubunda 1444,73 ± 611,30 pg / mL ve kontrol grubunda 1204,26 ± 660,88 pg / mL idi ve istatistiksel olarak benzerdi. PKOS grubunun vücut kitle indeksi (VKİ) ve bel/kalça oranı (BKO) değerleri, istatistiksel olarak anlamlı olmamasına rağmen, kontrol grubuna göre daha yüksekti.SONUÇ: Bu çalışma, PKOS'lu kadınlarla sağlıklı bireyler arasında, Scl ve DKK1 düzeyleri bakımından anlamlı bir fark olmadığını göstermiştir. Amenore PKOS olgularında kemik kaybına neden olsa da, hiperandrojenemi ve hiperöstrojeneminin kemik yoğunluğu üzerindeki olumlu etkileri dengeleyici bir unsur olarak kabul edilebilir.
- 1 October 2015
- Published by Elsevier in Journal of Affective Disorders
- Vol. 185, 214-218
Evaluation of affective temperament and anxiety–depression levels of patients with polycystic ovary syndrome
- 1 October 2015
- Published by Elsevier in Journal of Affective Disorders
- Vol. 185, 214-218
Evaluation of affective temperament and anxiety–depression levels of patients with polycystic ovary syndrome
- 1 September 2015
- Vol. 65 (9) , 1022-3
Severe hyperparathyroidism in patient with right thyroid hemiagenesis.
Thyroid hemiagenesis is an infrequent congenital disorder which is rarely associated with hyperparathyroidism. We present a case of an adult woman who presented with hyperparathyroidism and ipsilateral thyroid hemiagenesis. Parathyroid adenoma was excised by minimal invasive parathyroidectomy.
- 1 September 2015
- Vol. 65 (9) , 1022-3
Severe hyperparathyroidism in patient with right thyroid hemiagenesis.
Thyroid hemiagenesis is an infrequent congenital disorder which is rarely associated with hyperparathyroidism. We present a case of an adult woman who presented with hyperparathyroidism and ipsilateral thyroid hemiagenesis. Parathyroid adenoma was excised by minimal invasive parathyroidectomy.
- 1 August 2015
- Published by Elsevier in Journal of Biotechnology
- Vol. 208, S85
The RFLP profiles at BRAF V600E mutations in thyroid FNAB nodules
- 1 August 2015
- Published by Elsevier in Journal of Biotechnology
- Vol. 208, S85
The RFLP profiles at BRAF V600E mutations in thyroid FNAB nodules
- 17 April 2014
- Published by Bioscientifica in Endocrine Abstracts
Evaluation of epicardial adipose tissue thickness in patients with overt hyperthyroidism
Objective: Thyroid diseases are among the most common endocrine disease and with a prevalence of 1.2%. Thyroid hormones have several effects on cardiovascular system. Many studies showed the association between hyperthyroidism and acute ischemic heart disease with conflicting results. Epicardial adipose tissue (EAT) thickness is a marker of atherosclerosis and independent predictor of coronary artery disease. In this study, we aimed to evaluate the EAT thickness in patients with overt hyperthyroidism (OH). Materials and methods: Thirty newly diagnosed untreated OH patients and 44 control subjects were included in the this study. EAT thickness and carotid intima media thickness (CIMT) were measured by echocardiography. Results: EAT thickness and CIMT were higher (4.31±1.12 mm, 3.11±0.84 mm, PP<0.01 respectively) in OH patients than in healthy subjects. Conclusion: In conclusion, EAT thickness was higher in OH patients, therefore EAT thickness together with CIMT may be used as markers of early atherosclerosis in OH patients which had higher cardiovascular mortality than normal population.
- 17 April 2014
- Published by Bioscientifica in Endocrine Abstracts
Evaluation of epicardial adipose tissue thickness in patients with overt hyperthyroidism
Objective: Thyroid diseases are among the most common endocrine disease and with a prevalence of 1.2%. Thyroid hormones have several effects on cardiovascular system. Many studies showed the association between hyperthyroidism and acute ischemic heart disease with conflicting results. Epicardial adipose tissue (EAT) thickness is a marker of atherosclerosis and independent predictor of coronary artery disease. In this study, we aimed to evaluate the EAT thickness in patients with overt hyperthyroidism (OH). Materials and methods: Thirty newly diagnosed untreated OH patients and 44 control subjects were included in the this study. EAT thickness and carotid intima media thickness (CIMT) were measured by echocardiography. Results: EAT thickness and CIMT were higher (4.31±1.12 mm, 3.11±0.84 mm, PP<0.01 respectively) in OH patients than in healthy subjects. Conclusion: In conclusion, EAT thickness was higher in OH patients, therefore EAT thickness together with CIMT may be used as markers of early atherosclerosis in OH patients which had higher cardiovascular mortality than normal population.
- 17 April 2014
- Published by Bioscientifica in Endocrine Abstracts
Plasma levels of nesfatin-1 in patients with polycystic ovary syndrome
Introduction: Polycycstic ovary syndrome (PCOS) is an important disorder in women of reproductive age which is characterised with menstrual dysfunction, anovulation and hyperandrogenism. 5–10% of the female population affected by this syndrome. Nesfatin-1 is a new anorexigenic hormone which is expressed from several regions of hypothalamus and peripheral tissues. Nesfatin-1 is related with obesity, insulin resistance and appetite. We aimed to evaluated the nesfatin-1 levels in patients with PCOS. Materials and methods: Sixty-five patients (37 patients with PCOS and 28 healthy control subjects) were enrolled in the study. We included newly diagnosed patients with PCOS in our study. Diagnosis of PCOS was based on the 2003 ESHRE/ASRM diagnostic criteria. Results: The patients with PCOS and controls were similar in terms of mean age BMI, W:H ratio and HOMA–IR index. Plasma nesfatin-1 levels were similar between groups. There was no correlation between plasma nesfatin-1 levels and other parameters. Conclusion: In conclusion nesfatin-1 may be play important role in glucose metabolism and insulin resistance. In this study due to the absence of insulin resistance in PCOS patients, levels of nesfatin-1 were similar with control group. Nesfatin levels were associated with glucose metabolism, but further studies are needed in this regard.
- 17 April 2014
- Published by Bioscientifica in Endocrine Abstracts
Plasma levels of nesfatin-1 in patients with polycystic ovary syndrome
Introduction: Polycycstic ovary syndrome (PCOS) is an important disorder in women of reproductive age which is characterised with menstrual dysfunction, anovulation and hyperandrogenism. 5–10% of the female population affected by this syndrome. Nesfatin-1 is a new anorexigenic hormone which is expressed from several regions of hypothalamus and peripheral tissues. Nesfatin-1 is related with obesity, insulin resistance and appetite. We aimed to evaluated the nesfatin-1 levels in patients with PCOS. Materials and methods: Sixty-five patients (37 patients with PCOS and 28 healthy control subjects) were enrolled in the study. We included newly diagnosed patients with PCOS in our study. Diagnosis of PCOS was based on the 2003 ESHRE/ASRM diagnostic criteria. Results: The patients with PCOS and controls were similar in terms of mean age BMI, W:H ratio and HOMA–IR index. Plasma nesfatin-1 levels were similar between groups. There was no correlation between plasma nesfatin-1 levels and other parameters. Conclusion: In conclusion nesfatin-1 may be play important role in glucose metabolism and insulin resistance. In this study due to the absence of insulin resistance in PCOS patients, levels of nesfatin-1 were similar with control group. Nesfatin levels were associated with glucose metabolism, but further studies are needed in this regard.
- 17 April 2014
- Published by Bioscientifica in Endocrine Abstracts
Are small adrenal incidentalomas solely a radiological finding?
Introduction: The criteria defining the threshold size of adrenal incidentaloma (AI) are >1 cm diameter. However, data about AI ≤1 cm diameter is scant. The aim of this study is to evaluate function of adrenal masses ≤1 cm and to compare them with adrenal masses >1 cm as well as to understand the possible utility of determining salivary cortisol in diagnosis of SCS in patients with AI. Method: The study included 137 consecutive patients with AI (38 and 99 AI at ≤1 and >1 respectively). Results: SCS was 5.3 and 17.2% in AI ≤1 cm and >1 m diameter, respectively. The patients with >1 cm AI had a higher prevalence of SCS and primary hyperaldosteronism than patients with >1 cm AI did, but they did not differ significantly. The prevalence of diabetes and hypertension was high both in non-functional AI with ≤1 and >1 patients and showed no significant difference between two groups. Using a cut-off of 0.33 μg/dl for midnight salivary cortisol (MNSC), sensitivity, specificity, values of positive and negative predictivity for diagnosis of SCS were 58, 86, 40.7 and 91.8% respectively. Conclusion: The AI ≤1 cm harboured SCS as was the case in AI >1 cm. Similar to AI >1 cm, non-functional AI ≤1 cm also had higher prevalence of diabetes and hypertension. Furthermore, MNSC in patients with AI was found comparable with midnight serum cortisol in diagnoses of SCS.
- 17 April 2014
- Published by Bioscientifica in Endocrine Abstracts
Are small adrenal incidentalomas solely a radiological finding?
Introduction: The criteria defining the threshold size of adrenal incidentaloma (AI) are >1 cm diameter. However, data about AI ≤1 cm diameter is scant. The aim of this study is to evaluate function of adrenal masses ≤1 cm and to compare them with adrenal masses >1 cm as well as to understand the possible utility of determining salivary cortisol in diagnosis of SCS in patients with AI. Method: The study included 137 consecutive patients with AI (38 and 99 AI at ≤1 and >1 respectively). Results: SCS was 5.3 and 17.2% in AI ≤1 cm and >1 m diameter, respectively. The patients with >1 cm AI had a higher prevalence of SCS and primary hyperaldosteronism than patients with >1 cm AI did, but they did not differ significantly. The prevalence of diabetes and hypertension was high both in non-functional AI with ≤1 and >1 patients and showed no significant difference between two groups. Using a cut-off of 0.33 μg/dl for midnight salivary cortisol (MNSC), sensitivity, specificity, values of positive and negative predictivity for diagnosis of SCS were 58, 86, 40.7 and 91.8% respectively. Conclusion: The AI ≤1 cm harboured SCS as was the case in AI >1 cm. Similar to AI >1 cm, non-functional AI ≤1 cm also had higher prevalence of diabetes and hypertension. Furthermore, MNSC in patients with AI was found comparable with midnight serum cortisol in diagnoses of SCS.
- 27 February 2014
- Published by Acta Medica Anatolia in Acta Medica Anatolia
- Vol. 2 (4)
Aggressive Papillary Thyroid Carcinoma without Brafv600e Mutation
Aggressive Papillary Thyroid Carcinoma without Brafv600e Mutation
- 27 February 2014
- Published by Acta Medica Anatolia in Acta Medica Anatolia
- Vol. 2 (4)
Aggressive Papillary Thyroid Carcinoma without Brafv600e Mutation
Aggressive Papillary Thyroid Carcinoma without Brafv600e Mutation
- 26 February 2014
- Published by Acta Medica Anatolia in Acta Medica Anatolia
- Vol. 2 (3) , 111
Graves‘ Disease Associated with Severe Hypoalbuminemia
- 26 February 2014
- Published by Acta Medica Anatolia in Acta Medica Anatolia
- Vol. 2 (3) , 111
Graves‘ Disease Associated with Severe Hypoalbuminemia